| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 6431 |
| 1 | SOMATROPIN | 5061 |
| 2 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 3401 |
| 3 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 2341 |
| 4 | INSULIN GLARGINE | 2005 |
| 5 | UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 1681 |
| 6 | MEPOLIZUMAB | 1645 |
| 7 | BELIMUMAB | 1635 |
| 8 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 1523 |
| 9 | FLUTICASONE PROPIONATE AND SALMETEROL | 1514 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALBUTEROL SULFATE AND BUDESONIDE | 168 | 0.1051 |
| 1 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 3401 | 0.0789 |
| 2 | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | 150 | 0.0762 |
| 3 | OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | 144 | 0.0708 |
| 4 | SOMATROPIN | 5061 | 0.0676 |
| 5 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 2341 | 0.0647 |
| 6 | BELIMUMAB | 1635 | 0.0510 |
| 7 | SOMATROGON-GHLA | 49 | 0.0393 |
| 8 | ESTRADIOL AND LEVONORGESTREL | 76 | 0.0369 |
| 9 | MEPOLIZUMAB | 1645 | 0.0326 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2518 |
| 1 | Insulin Analog [EPC] | 2341 |
| 2 | Interleukin-5 Antagonist [EPC] | 1645 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1635 |
| 4 | PCSK9 Inhibitor [EPC] | 1057 |
| 5 | GLP-1 Receptor Agonist [EPC] | 712 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 676 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 672 |
| 8 | Interleukin-17A Antagonist [EPC] | 589 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 572 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1645 | 2.3910 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1635 | 0.0510 |
| 2 | PCSK9 Inhibitor [EPC] | 1057 | 0.0410 |
| 3 | Recombinant Human Growth Hormone [EPC] | 521 | 0.0237 |
| 4 | Interleukin-17A Antagonist [EPC] | 589 | 0.0158 |
| 5 | Provitamin D2 Compound [EPC] | 390 | 0.0131 |
| 6 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 241 | 0.0115 |
| 7 | Catechol-O-Methyltransferase Inhibitor [EPC] | 53 | 0.0105 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 21 | 0.0101 |
| 9 | Thymic Stromal Lymphopoietin Blocker [EPC] | 68 | 0.0098 |